Apolipoprotein E and methylenetetrahydrofolate reductase genetic polymorphisms in relation to other risk factors for cardiovascular disease in UK Caucasians and Black South Africans

Atherosclerosis

Volumn 145, Issue 1, 1999, Pages 125-135

  Loktionov, Alexandre ^a   Vorster, Hester ^b   O'Neill, Ian K ^a   Nell, Theo ^b   Bingham, Sheila A ^a   Runswick, Shirley A ^a   Cummings, John H ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b NORTH WEST UNIVERSITY   (South Africa)

Author keywords

Blood lipids; Coronary heart disease; Ethnicity; Genetic polymorphisms

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); APOLIPOPROTEIN E; CHOLESTEROL; FIBRINOGEN; LIPOPROTEIN; TRIACYLGLYCEROL;

ALLELE; AMINO ACID METABOLISM; ARTICLE; CARDIOVASCULAR RISK; CAUCASIAN; CHOLESTEROL BLOOD LEVEL; ETHNOLOGY; FIBRINOGEN BLOOD LEVEL; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; ISCHEMIC HEART DISEASE; LIPID METABOLISM; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; NEGRO; PRIORITY JOURNAL; RACE DIFFERENCE; SOUTH AFRICA; TRIACYLGLYCEROL BLOOD LEVEL; UNITED KINGDOM;

AFRICAN CONTINENTAL ANCESTRY GROUP; ALLELES; APOLIPOPROTEINS E; BLOOD PRESSURE; CORONARY DISEASE; EUROPEAN CONTINENTAL ANCESTRY GROUP; FIBRINOGEN; GENOTYPE; GREAT BRITAIN; HUMANS; LIPIDS; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); OXIDOREDUCTASES ACTING ON CH-NH GROUP DONORS; POLYMORPHISM, GENETIC; RISK FACTORS; SOUTH AFRICA;

EID: 0032974899     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0021-9150(99)00022-2     Document Type: Article

References (52)

1. Castelli W.P. Lipids, risk factors and ischaemic heart disease. Atherosclerosis. 124((Suppl)):1996;S1-S9.
2. Galton D.J. Genetic determinants of atherosclerosis-related dyslipidemias and their clinical implications. Clin Chim Acta. 257:1997;181-197.
3. Dammerman M., Breslow J.L. Genetic basis of lipoprotein disorders. Circulation. 91:1995;505-512.
4. Davignon J., Cregg R.E., Sing C.F. Apolipoprotein E polymorphism and atherosclerosis. Arteriosclerosis. 9:1988;405-411.
5. Mahley R.W. Apolipoprotein E: cholesterol transport protein with expanding role in cell biology. Science. 240:1988;622-630.
6. Wilson P.F., Myers R.H., Larson M.G., Ordovas J.M., Wolf P.A., Schaefer E.J. Apolipoprotein E alleles, dyslipidemia and coronary heart disease. The Framingham Offspring Study. J Am Med Assoc. 272:1994;1666-1671.
7. Wilson P.W.F., Schaeffer E.J., Larson M.G., Ordovas J.M. Apolipoprotein-e alleles and risk of coronary disease-a metaanalysis. Arterioscler Thromb Vasc Biol. 16:1996;1250-1255.
8. Stengård J.H., Weiss K.M., Sing C.F. An ecological study of association between coronary heart disease mortality rates in men and the relative frequencies of common allelic variations in the gene coding for apolipoprotein E. Hum Genet. 103:1998;234-241.
9. Pedro-Botet J., Sentì M., Nogues X. et al. Lipoprotein and apolipoprotein profile in men with ischemic stroke: role of lipoprotein(a), triglyceride-rich lipoproteins, and apolipoprotein E polymorphism. Stroke. 23:1992;1556-1562.
10. Margaglione M., Seripa D., Gravina C. et al. Prevalence of apolipoprotein E alleles in healthy subjects and survivors of ischemic stroke. Stroke. 29:1998;399-403.
11. Weisgraber K.H., Mahley R.W. Human apolipoprotein E: the Alzheimer's disease connection. FASEB J. 10:1996;1485-1494.
12. Graham I.M., Daly L.E., Refsum H.M. et al. Plasma homocysteine as a risk factor for vascular disease. J Am Med Assoc. 277:1997;1775-1781.
13. Welch G.H., Loscalzo J. Homocysteine and atherothrombosis. New Engl J Med. 338:1998;1042-1050.
14. Nygård O., Nordrehaug J.E., Refsum H., Ueland P.M., Farstad M., Vollset S.E. Plasma homocysteine levels and mortality in patients with coronary heart disease. New Engl J Med. 337:1997;230-236.
15. Kang S.S., Wong P.W.K., Susmano A., Sora J., Norusis M., Ruggie N. Thermolabile methylenetetrahydrofolate reductase: an inherited risk factor for coronary artery disease. Am J Hum Genet. 48:1991;536-545.
16. Frosst P., Blom H.J., Milos R. et al. A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nat Genet. 10:1995;111-113.
17. Gallagher P.M., Meleady R., Shields D.C. et al. Homocysteine and risk of premature coronary heart disease: Evidence for a common gene mutation. Circulation. 94:1996;2154-2158.
18. Kluijtmans L.A.J., Kastelein J.J.P., Lindemans J. et al. Thermolabile methylenetetrahydrofolate reductase in coronary artery disease. Circulation. 96:1997;2573-2577.
19. Jacques P.F., Bostom A.G., Williams R.R. et al. Relation between folate status, a common mutation in methylenetetrahydrofolate reductase, and plasma homocysteine concentrations. Circulation. 93:1996;7-9.
20. Gudnason V., Stansbie D., Scott J. et al. C677T (thermolabile alanine/valine) polymorphism in methylenetetrahydrofolate reductase (MTHFR): its frequency and impact on plasma homocysteine concentration in different European populations. Atherosclerosis. 136:1998;347-354.
21. Ou T., Yamakawa-Kobayashi K., Arinami T. et al. Methylenetetrahydrofolate reductase and apolipoprotein E polymorphisms are independent risk factors for coronary heart disease in Japanese: a case-control study. Atherosclerosis. 137:1998;23-28.
22. Schmitz C., Lindpaintner K., Verhoef P., Gaziano J.M., Buring J. Genetic polymorphism of methylenetetrahydrofolate reductase and myocardial infarction. Circulation. 94:1996;1812-1814.
23. van Broxmeer F.M., Mamotte C.D.S., Vasikaran S.D., Taylor R.R. Methylenetetrahydrofolate reductase gene and coronary artery disease. Circulation. 95:1997;21-23.
24. Schwartz S.M., Siscovick D.S., Malinow M.R. et al. Myocardial infarction in young women in relation to plasma total homocysteine, folate, and a common variant in the methylenetetrahydrofolate reductase gene. Circulation. 96:1997;412-417.
25. Verhoef P., Rimm E.B., Hunter D.J. et al. A common mutation in the methylenetetrahydrofolate reductase gene and risk of coronary heart disease: results among US men. J Am Coll Cardiol. 32:1998;353-359.
26. Cobbaert C., Mulder P. Regional serum cholesterol differences in Belgium: do genetically determined cardiovascular risk factors contribute? Int J Epidemiol. 27:1998;605-613.
27. Deiana L., Pes G.M., Carru C. et al. Lack of influence of apolipoprotein E4 on lipoprotein levels in the island population of Sardinia. Eur J Clin Invest. 28:1998;290-294.
28. Morita H., Taguchi J., Kurihara H. et al. Genetic polymorphism of 5,10-methylenetetrahydrofolate reductase (MTHFR) as a risk factor for coronary heart disease. Circulation. 95:1997;2032-2036.
29. Hallman D.M., Boerwinkle E., Saha N. et al. The apolipoprotein E polymorphism: a comparison of allele frequencies and effects in nine populations. Am J Hum Genet. 49:1991;338-349.
30. Kamboh M.I., Weiss K.M., Ferrell R.E. Genetic studies of human apolipoproteins. XVI. Apo E polymorphism and cholesterol levels in the Mayans of the Yucatan Peninsula, Mexico. Clin Genet. 39:1991;26-32.
31. Kamboh M.I., Aston C.E., Hamman R.F. The relationship of apo E polymorphism and cholesterol levels in normoglycemic and diabetic subjects in a biethnic population from the San Luis Valley, Colorado. Atherosclerosis. 112:1995;145-159.
32. Kamboh M.I., Bhatia K.K., Ferrell R.E. Genetic studies of human apolipoproteins. XII. Population genetics of apolipoprotein polymorphisms in Papua New Guinea. Am J Hum Biol. 2:1990;17-23.
33. Sandholzer C., Delport R., Vermaak H., Utermann G. High frequency of the apo e4 allele in Khoi San from South Africa. Hum Genet. 95:1995;46-48.
34. Zekraoui L., Lagarde J.P., Raisonnier A., Gerard N., Aoizerate A., Lucotte G. High frequency of the apolipoprotein E*4 allele in African pygmies and most of the African populations in sub-Saharan Africa. Hum Biol. 69:1997;575-581.
35. Scheer W.D., Boudreau D.A., Malcolm G.T., Middaugh J.P. Apolipoprotein E and atherosclerosis in Alaska Natives. Atherosclerosis. 114:1995;197-202.
36. Sepehrnia B., Kamboh M.I., Adams-Campbell L.L. et al. Genetic studies of human apolipoproteins. X. The effect of the apolipoprotein E polymorphism on quantitative levels of lipoproteins in Nigerian Blacks. Am J Hum Genet. 45:1989;586-591.
37. Scott J., Weir D. Homocysteine and cardiovascular disease. Q J Med. 89:1996;561-563.
38. Sohda S., Arinami T., Hamada H., Yamada N., Hamaguchi H., Kubo T. Methylenetetrahydrofolate reductase polymorphism and pre-eclampsia. J Med Genet. 34:1997;525-526.
39. Stevenson R.E., Schwartz C.E., Du Y.-Z., Adams M.J. Differences in methylenetetrahydrofolate reductase genotype frequencies between Whites and Blacks. Am J Hum Genet. 60:1997;229-230.
40. Hegele R.A., Tulli C., Young T.K., Connelly P. V677 mutation of methylenetetrahydrofolate reductase and cardiovascular disease in Canadian Innuit. Lancet. 349:1997;1221-1222.
41. Seedat Y.K. Ethnicity, hypertension, coronary heart disease and renal diseases in South Africa. Ethn Health. 1:1996;349-357.
42. Walker A.R.P., Sareli P. Coronary heart disease: outlook for Africa. J R Soc Med. 90:1997;23-27.
43. Loktionov A., Bingham S.A., Vorster H., Jerling J.C., Runswick S.A., Cummings J.H. Apolipoprotein E genotype modulates the effect of black tea drinking on blood lipids and blood coagulation factors: a pilot study. Br J Nutr. 79:1998;133-139.
44. Bohnet K., Regis-Bailly A., Vincent-Viry M., Schlenck A., Gueguen R., Siest G., Visvikis S. Apolipoprotein E genotype ε4/ε2 in the STANISLAS cohort study - dominance of the ε2 allele? Ann Hum Genet. 60:1996;509-516.
45. Vorster H.H., Venter C.S., Menssink E. et al. Adequate nutritional status despite restricted dietary variety in adult rural Vendas. S Afr J Clin Nutr. 7:1994;3-16.
46. Adams M., Smith P.D., Martin D., Thompson J.R., Lodwick D., Samani N.J. Genetic analysis of thermolabile methylenetetrahydrofolate reductase as a risk factor for myocardial infarction. Q J Med. 89:1996;437-444.
47. Jorde L.B., Rogers A.R., Bamshad M. et al. Microsatellite diversity and the demographic history of modern humans. Proc Natl Acad Sci USA. 94:1997;3100-3103.
48. Hanlon C.S., Rubinsztein D.C. Arginine residues at codon 112 and codon 158 in the apolipoprotein -E gene correspond to the ancestral state in humans. Atherosclerosis. 112:1995;85-90.
49. Oelofse A., Jooste P.L., Steyn K. et al. The lipid and lipoprotein profile of the urban black South African population of the Cape Peninsula - the BRISK study. S Afr Med J. 86:1996;162-166.
50. Steyn K., Katzenellenbogen J.M., Lombard C.J., Bourne D. Urbanization and the risk for chronic diseases of lifestyle in the black population of the Cape Peninsula, South Africa. J Cardiovasc Risk. 4:1997;135-142.
51. de Villiers C., Louw S.J. Determining the prevalence of Alzheimer's disease in elderly South Africans. S Afr Med J. 86:1996;135-136.
52. Tang M.-X., Stern Y., Marder K. et al. The apo E-ε4 allele and the risk of Alzheimer disease among African Americans, Whites, and Hispanics. J Am Med Assoc. 279:1998;751-755.